SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-037345
Filing Date
2021-02-11
Accepted
2021-02-11 07:36:00
Documents
13
Period of Report
2021-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d127706d8k.htm   iXBRL 8-K 27408
2 EX-99.1 d127706dex991.htm EX-99.1 8390
  Complete submission text file 0001193125-21-037345.txt   163049

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtem-20210210.xsd EX-101.SCH 3057
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20210210_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20210210_pre.xml EX-101.PRE 11399
6 EXTRACTED XBRL INSTANCE DOCUMENT d127706d8k_htm.xml XML 3407
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 21616735
SIC: 2834 Pharmaceutical Preparations